Brain science learns about sight from computer science—and vice versa

Researchers studying the basis of visual recognition in two distinct disciplines—computer science and brain science—have put their heads together to advance both fields at once.

Specifically, they’ve captured the brain activity of four people viewing each image in a 5,000-image set, then drawn from a deep-learning algorithm trained on the same image set to better understand how the brain processes visual information.

The hope is that this insight, in turn, will symbiotically improve deep-learning methodologies going forward.  

The team, comprising experts from Carnegie Mellon University in Pittsburgh and Fordham University in New York City, described their work in a study published online May 6 in Scientific Data.

The four volunteers who viewed the images underwent functional MRI (fMRI) brain scanning totaling at least 20 hours each.

“The extreme design decision to run the same individuals over so many sessions was necessary for disentangling the neural responses associated with individual images,” the team explained in a news release sent by Carnegie Mellon.

“As we learn more about the neural basis of visual recognition, we will also be better positioned to contribute to advances in artificial vision,” added study co-author Michael Tarr, who heads Carnegie Mellon’s psychology department.

Tarr pointed out that, while the study’s image dataset was hefty relative to others used in prior research, much larger sets are needed to advance computer-vision models as well as neuroscience’s understanding of biological vision.

A reasonable fMRI dataset “would require at least 50,000 stimulus images and many more volunteers to make headway in light of the fact that the class of deep neural nets used to analyze visual imagery are trained on millions of images,” Tarr said.

Click here to read the full study for free and here for the news release.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.